Connect with us

International Circuit

Glaukos Announces Participation In Piper Jaffray Healthcare Conference

SAN CLEMENTE, Calif.– Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that its management is scheduled to participate in the Piper Jaffray Healthcare Conference on Wednesday, December 4, 2019, at 2:30 p.m. EST in New York City.

A live audio webcast for this event will be available in the Investors section of the Glaukos website at http://investors.glaukos.com and will be archived for 90 days.-Bio Space

Copyright © 2024 Medical Buyer

error: Content is protected !!